140 related articles for article (PubMed ID: 12386117)
1. Docetaxel (Taxotere) is not metabolized by recombinant human CYP1B1 in vitro, but acts as an effector of this isozyme.
Bournique B; Lemarié A
Drug Metab Dispos; 2002 Nov; 30(11):1149-52. PubMed ID: 12386117
[TBL] [Abstract][Full Text] [Related]
2. Role of human cytochrome P450 3A4 and 3A5 in the metabolism of taxotere and its derivatives: enzyme specificity, interindividual distribution and metabolic contribution in human liver.
Shou M; Martinet M; Korzekwa KR; Krausz KW; Gonzalez FJ; Gelboin HV
Pharmacogenetics; 1998 Oct; 8(5):391-401. PubMed ID: 9825831
[TBL] [Abstract][Full Text] [Related]
3. Cytochrome P450 CYP1B1 protein expression: a novel mechanism of anticancer drug resistance.
McFadyen MC; McLeod HL; Jackson FC; Melvin WT; Doehmer J; Murray GI
Biochem Pharmacol; 2001 Jul; 62(2):207-12. PubMed ID: 11389879
[TBL] [Abstract][Full Text] [Related]
4. Bioflavonoids: selective substrates and inhibitors for cytochrome P450 CYP1A and CYP1B1.
Doostdar H; Burke MD; Mayer RT
Toxicology; 2000 Apr; 144(1-3):31-8. PubMed ID: 10781868
[TBL] [Abstract][Full Text] [Related]
5. Metabolism of docetaxel by human cytochromes P450: interactions with paclitaxel and other antineoplastic drugs.
Royer I; Monsarrat B; Sonnier M; Wright M; Cresteil T
Cancer Res; 1996 Jan; 56(1):58-65. PubMed ID: 8548776
[TBL] [Abstract][Full Text] [Related]
6. Enzymatic characterization of in vitro-expressed Baikal seal cytochrome P450 (CYP) 1A1, 1A2, and 1B1: implication of low metabolic potential of CYP1A2 uniquely evolved in aquatic mammals.
Iwata H; Yamaguchi K; Takeshita Y; Kubota A; Hirakawa S; Isobe T; Hirano M; Kim EY
Aquat Toxicol; 2015 May; 162():138-151. PubMed ID: 25814058
[TBL] [Abstract][Full Text] [Related]
7. Regioselective metabolism of taxoids by human CYP3A4 and 2C8: structure-activity relationship.
Cresteil T; Monsarrat B; Dubois J; Sonnier M; Alvinerie P; Gueritte F
Drug Metab Dispos; 2002 Apr; 30(4):438-45. PubMed ID: 11901098
[TBL] [Abstract][Full Text] [Related]
8. Oxidation of xenobiotics by recombinant human cytochrome P450 1B1.
Shimada T; Gillam EM; Sutter TR; Strickland PT; Guengerich FP; Yamazaki H
Drug Metab Dispos; 1997 May; 25(5):617-22. PubMed ID: 9152602
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of procarcinogen-bioactivating human CYP1A1, CYP1A2 and CYP1B1 enzymes by melatonin.
Chang TK; Chen J; Yang G; Yeung EY
J Pineal Res; 2010 Jan; 48(1):55-64. PubMed ID: 19919601
[TBL] [Abstract][Full Text] [Related]
10. Cytochrome P450 1A1 and 1B1 in human blood lymphocytes are not suitable as biomarkers of exposure to dioxin-like compounds: polymorphisms and interindividual variation in expression and inducibility.
van Duursen MB; Sanderson JT; van den Berg M
Toxicol Sci; 2005 May; 85(1):703-12. PubMed ID: 15659568
[TBL] [Abstract][Full Text] [Related]
11. The effect of granisetron on in vitro metabolism of paclitaxel and docetaxel.
Watanabe Y; Nakajima H; Nozaki K; Hoshiai H; Noda K
Cancer J; 2003; 9(1):67-70. PubMed ID: 12602770
[TBL] [Abstract][Full Text] [Related]
12. Different in vitro metabolism of paclitaxel and docetaxel in humans, rats, pigs, and minipigs.
Vaclavikova R; Soucek P; Svobodova L; Anzenbacher P; Simek P; Guengerich FP; Gut I
Drug Metab Dispos; 2004 Jun; 32(6):666-74. PubMed ID: 15155559
[TBL] [Abstract][Full Text] [Related]
13. A methoxyflavonoid, chrysoeriol, selectively inhibits the formation of a carcinogenic estrogen metabolite in MCF-7 breast cancer cells.
Takemura H; Uchiyama H; Ohura T; Sakakibara H; Kuruto R; Amagai T; Shimoi K
J Steroid Biochem Mol Biol; 2010 Jan; 118(1-2):70-6. PubMed ID: 19833205
[TBL] [Abstract][Full Text] [Related]
14. Human CYP1B1 and anticancer agent metabolism: mechanism for tumor-specific drug inactivation?
Rochat B; Morsman JM; Murray GI; Figg WD; McLeod HL
J Pharmacol Exp Ther; 2001 Feb; 296(2):537-41. PubMed ID: 11160641
[TBL] [Abstract][Full Text] [Related]
15. Molecular characterization of cytochrome P450 1A1, 1A2, and 1B1, and effects of polychlorinated dibenzo-p-dioxin, dibenzofuran, and biphenyl congeners on their hepatic expression in Baikal seal (Pusa sibirica).
Hirakawa S; Iwata H; Takeshita Y; Kim EY; Sakamoto T; Okajima Y; Amano M; Miyazaki N; Petrov EA; Tanabe S
Toxicol Sci; 2007 Jun; 97(2):318-35. PubMed ID: 17383972
[TBL] [Abstract][Full Text] [Related]
16. Role of human cytochrome P450 1A1, 1A2, 1B1, and 3A4 in the 2-, 4-, and 16alpha-hydroxylation of 17beta-estradiol.
Badawi AF; Cavalieri EL; Rogan EG
Metabolism; 2001 Sep; 50(9):1001-3. PubMed ID: 11555828
[TBL] [Abstract][Full Text] [Related]
17. Effect of frying-meat emission particulate on 17beta-estradiol 2- and 4-hydroxylation in human lung adenocarcinoma CL5 cells.
Wang HW; Ueng TH; Chen TL; Yang PC
J Toxicol Environ Health A; 2003 Jun; 66(12):1175-88. PubMed ID: 12791542
[TBL] [Abstract][Full Text] [Related]
18. Effects of zearalenone on mRNA expression and activity of cytochrome P450 1A1 and 1B1 in MCF-7 cells.
Yu Z; Hu D; Li Y
Ecotoxicol Environ Saf; 2004 Jun; 58(2):187-93. PubMed ID: 15157572
[TBL] [Abstract][Full Text] [Related]
19. Potent inhibition of human cytochrome P450 1B1 by tetramethoxystilbene.
Chun YJ; Oh YK; Kim BJ; Kim D; Kim SS; Choi HK; Kim MY
Toxicol Lett; 2009 Aug; 189(1):84-9. PubMed ID: 19463925
[TBL] [Abstract][Full Text] [Related]
20. Hepatic biotransformation of docetaxel (Taxotere) in vitro: involvement of the CYP3A subfamily in humans.
Marre F; Sanderink GJ; de Sousa G; Gaillard C; Martinet M; Rahmani R
Cancer Res; 1996 Mar; 56(6):1296-302. PubMed ID: 8640817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
